Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T15:01:32.252Z.
Calculation as of: 2026-10-06T15:01:32.252Z.
Quote observation: 2026-10-06T15:00:30.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 47c8a7f7872550f4b91559d6c77d4467729e005a9c3786f3e3eb9faa26d80d2a
PE RATIO
N/A
PE RATIO AVG TTM
N/A
PE RATIO AVG 3Y
N/A
PE RATIO AVG 5Y
N/A
PE RATIO AVG 10Y
N/A
PE RATIO AVG 15Y
N/A
PE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$721.26M
PE Ratio
N/A
TTM Avg
991.02
3Y Avg
502.52
5Y Avg
502.52
Market Cap
$709.16M
PE Ratio
17.63
TTM Avg
23.33
3Y Avg
39.10
5Y Avg
32.90
Market Cap
$695.21M
PE Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | $719.62M | N/A | N/A | N/A | N/A |
| Cytek Biosciences, Inc. (CTKB)vs › | $721.26M | N/A | 991.02 | 502.52 | 502.52 |
| Achieve Life Sciences, Inc. (ACHV)vs › | $731.45M | N/A | N/A | N/A | N/A |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $709.16M | 17.63 | 23.33 | 39.10 | 32.90 |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $707.95M | N/A | N/A | N/A | N/A |
| Faeth Therapeutics, Inc. (FTH)vs › | $708.93M | N/A | N/A | N/A | N/A |
| Anteris Technologies Global Corp. (AVR)vs › | $695.21M | N/A | N/A | N/A | N/A |
| Candel Therapeutics, Inc. (CADL)vs › | $753.58M | N/A | N/A | N/A | N/A |
| Design Therapeutics, Inc. (DSGN)vs › | $761.35M | N/A | N/A | N/A | N/A |
| Annexon, Inc. (ANNX)vs › | $679.13M | N/A | N/A | N/A | N/A |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$13.69
Forward EPS (Est.)
$-2.92
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PE RATIO |
|---|---|
| 2018-05-11 | 416.87 |
| 2018-05-10 | 463.33 |
| 2018-05-09 | 469.28 |
| 2018-05-08 | 489.53 |
| 2018-05-07 | 489.53 |
| 2018-05-04 | 481.19 |
| 2018-05-03 | 477.62 |
| 2018-05-02 | 488.34 |
| 2018-05-01 | 462.13 |
| 2018-04-30 | 443.08 |
| 2018-04-27 | 482.38 |
| 2018-04-26 | 501.44 |
| 2018-04-25 | 508.59 |
| 2018-04-24 | 534.79 |
| 2018-04-23 | 497.87 |
| 2018-04-20 | 464.52 |
| 2018-04-19 | 425.21 |
| 2018-04-18 | 407.34 |
| 2018-04-17 | 415.68 |
| 2018-04-16 | 407.34 |
| 2018-04-13 | 440.69 |
| 2018-04-12 | 449.03 |
| 2018-04-11 | 457.37 |
| 2018-04-10 | 475.24 |
| 2018-04-09 | 466.90 |
| 2018-04-06 | 493.10 |
| 2018-04-05 | 519.31 |
| 2018-04-04 | 509.78 |
| 2018-04-03 | 510.97 |
| 2018-04-02 | 448.37 |
| 2018-03-29 | 447.33 |
| 2018-03-28 | 407.70 |
| 2018-03-27 | 442.11 |
| 2018-03-26 | 449.41 |
| 2018-03-23 | 462.97 |
| 2018-03-22 | 493.21 |
| 2018-03-21 | 506.76 |
| 2018-03-20 | 535.96 |
| 2018-03-19 | 548.47 |
| 2018-03-16 | 545.34 |
| 2018-03-15 | 549.51 |
| 2018-03-14 | 541.17 |
| 2018-03-13 | 522.40 |
| 2018-03-12 | 537.00 |
| 2018-03-09 | 564.11 |
| 2018-03-08 | 560.98 |
| 2018-03-07 | 590.18 |
| 2018-03-06 | 537.00 |
| 2018-03-05 | 503.64 |
| 2018-03-02 | 514.06 |
| 2018-03-01 | 460.88 |
| 2018-02-28 | 485.91 |
| 2018-02-27 | 544.30 |
| 2018-02-26 | 516.15 |
| 2018-02-23 | 458.80 |
| 2018-02-22 | 421.99 |
| 2018-02-21 | 422.30 |
| 2018-02-20 | 404.58 |
| 2018-02-16 | 421.26 |
| 2018-02-15 | 391.02 |
| 2018-02-14 | 411.88 |
| 2018-02-13 | 353.48 |
| 2018-02-12 | 349.31 |
| 2018-02-09 | 318.03 |
| 2018-02-08 | 345.14 |
| 2018-02-07 | 360.78 |
| 2018-02-06 | 327.41 |
| 2018-02-05 | 340.97 |
| 2018-02-02 | 312.82 |
| 2018-02-01 | 331.69 |
| 2018-01-31 | 345.14 |
| 2018-01-30 | 351.40 |
| 2018-01-29 | 372.25 |
| 2018-01-26 | 361.82 |
| 2018-01-25 | 361.82 |
| 2018-01-24 | 332.63 |
| 2018-01-23 | 367.04 |
| 2018-01-22 | 334.71 |
| 2018-01-19 | 306.56 |
| 2018-01-18 | 275.28 |
| 2018-01-17 | 277.36 |
| 2018-01-16 | 271.11 |
| 2018-01-12 | 285.71 |
| 2018-01-11 | 281.54 |
| 2018-01-10 | 233.57 |
| 2018-01-09 | 263.81 |
| 2018-01-08 | 289.88 |
| 2018-01-05 | 310.73 |
| 2018-01-04 | 333.67 |
| 2018-01-03 | 338.88 |
| 2018-01-02 | 347.23 |
| 2017-12-29 | 333.67 |
| 2017-12-28 | 347.23 |
| 2017-12-27 | 421.26 |
| 2017-12-26 | 346.18 |
| 2017-12-22 | 315.94 |
| 2017-12-21 | 282.58 |
| 2017-12-20 | 261.72 |
| 2017-12-19 | 265.89 |
| 2017-12-18 | 226.27 |
| 2017-12-15 | 202.29 |
| 2017-12-14 | 199.16 |
| 2017-12-13 | 208.96 |
| 2017-12-12 | 194.99 |
| 2017-12-11 | 183.52 |
| 2017-12-08 | 175.18 |
| 2017-12-07 | 169.96 |
| 2017-12-06 | 156.41 |
| 2017-12-05 | 172.05 |
| 2017-12-04 | 185.60 |
| 2017-12-01 | 181.43 |
| 2017-11-30 | 185.60 |
| 2017-11-29 | 187.69 |
| 2017-11-28 | 137.64 |
| 2017-11-27 | 173.09 |
| 2017-11-24 | 123.04 |
| 2017-11-22 | 123.04 |
| 2017-11-21 | 122.00 |
| 2017-11-20 | 123.04 |
| 2017-11-17 | 117.83 |
| 2017-11-16 | 113.66 |
| 2017-11-15 | 115.74 |
| 2017-11-14 | 109.49 |
| 2017-11-13 | 105.31 |
| 2017-11-10 | 104.27 |
| 2017-11-09 | 110.53 |
| 2017-11-08 | 110.53 |
| 2017-11-07 | 114.70 |